Re: A new rabbit monoclonal antibody (4B5) for the immunohistochemical (IHC) determination of the HER2 status in breast cancer: Comparison with CB11, fluorescence in situ hybridization (FISH), and interlaboratory reproducibility

Applied Immunohistochemistry and Molecular Morphology

Volumn 16, Issue 5, 2008, Pages 510-511

  Egervari, Kristof ^a   Szollosi, Zoltan ^a   Nemes, Zoltan ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; MONOCLONAL ANTIBODY; TRASTUZUMAB; DIAGNOSTIC AGENT;

BREAST CANCER; CANCER CHEMOTHERAPY; COMPARATIVE STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; IMMUNOHISTOCHEMISTRY; LETTER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; SENSITIVITY AND SPECIFICITY; ANIMAL; BREAST TUMOR; CHEMISTRY; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; LABORATORY; NOTE; RABBIT; REPRODUCIBILITY; STANDARD;

ANIMALS; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LABORATORIES; RABBITS; RECEPTOR, ERBB-2; REPRODUCIBILITY OF RESULTS;

EID: 55949119274     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3180cc31fe     Document Type: Letter

References (5)

1. Powell WC, Hicks DG, Prescott N, et al. A new rabbit monoclonal antibody (4B5) for the immunohistochemical determination of the HER2 status in breast cancer: comparison with CB11, fluorescence in situ hybridization (FISH), and interlaboratory reproducibility. Appl Immunohistochem Mol Morphol. 2007;15:94-102. (Pubitemid 46673324)
2. Kobayashi M, Ooi A, Oda Y, et al. Protein overexpression and gene amplification of c-erbB-2 in breast carcinomas: a comparative study of immunohistochemistry and fluorescence in situ hybridization of formalin- fixed, paraffin-embedded tissues. Hum Pathol. 2002;33:21-28. (Pubitemid 34112949)
3. Seidman AD, Fornier MN, Esteva FJ, et al. Weekly Trastuzumab and Paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification. J Clin Oncol. 2001;19: 2587-2595.
4. Mass RD, Press MF, Anderson S, et al. Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumab. Clin Breast Cancer. 2005;6:240-246. (Pubitemid 47050800)
5. Wolff AC, Hammond MEH, Schwartz JN, et al. American Society of Clinical Oncology/ College of American Pathologists Guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007;25: 1-17.